Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya Simuni

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2021
Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's DiseaseConnie Marras, Kelly A Mills, Shirley Eberly, et al.
Annals of Neurology|May 6, 2026
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeLana M Chahine, Roy N Alcalay, Ethan G Brown, et al.
NPJ Parkinson'S Disease|October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortTanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
NPJ Parkinson'S Disease|December 5, 2019
Advance care planning in Parkinson's disease: ethical challenges and future directionsLeonard L Sokol, Michael J Young, Jack Paparian, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2023
Providing genetic testing and genetic counseling for Parkinson's disease to the communityLola Cook, Jennifer Verbrugge, Tae-Hwi Schwantes-An, et al.
CNS Spectrums|December 28, 2018
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensusKevin J Black, Henry Nasrallah, Stuart Isaacson, et al.
Parkinsonism & Related Disorders|July 9, 2010
Piloting the NPF data-driven quality improvement initiativeMichael S Okun, Andrew Siderowf, John G Nutt, et al.
Nature Medicine|April 15, 2024
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's diseaseGennaro Pagano, Kirsten I Taylor, Judith Anzures Cabrera, et al.
Movement Disorders Clinical Practice|April 11, 2017
Impact of Depression on Progression of Impairment and Disability in Early Parkinson's DiseaseDanny Bega, Sheng Luo, Hubert Fernandez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's DiseasePaulina Gonzalez-Latapi, Caroline Gochanour, Hyunkeun Cho, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2021
Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's DiseaseConnie Marras, Kelly A Mills, Shirley Eberly, et al.
Annals of Neurology|May 6, 2026
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeLana M Chahine, Roy N Alcalay, Ethan G Brown, et al.
NPJ Parkinson'S Disease|October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortTanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
NPJ Parkinson'S Disease|December 5, 2019
Advance care planning in Parkinson's disease: ethical challenges and future directionsLeonard L Sokol, Michael J Young, Jack Paparian, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2023
Providing genetic testing and genetic counseling for Parkinson's disease to the communityLola Cook, Jennifer Verbrugge, Tae-Hwi Schwantes-An, et al.
CNS Spectrums|December 28, 2018
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensusKevin J Black, Henry Nasrallah, Stuart Isaacson, et al.
Parkinsonism & Related Disorders|July 9, 2010
Piloting the NPF data-driven quality improvement initiativeMichael S Okun, Andrew Siderowf, John G Nutt, et al.
Nature Medicine|April 15, 2024
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's diseaseGennaro Pagano, Kirsten I Taylor, Judith Anzures Cabrera, et al.
Movement Disorders Clinical Practice|April 11, 2017
Impact of Depression on Progression of Impairment and Disability in Early Parkinson's DiseaseDanny Bega, Sheng Luo, Hubert Fernandez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's DiseasePaulina Gonzalez-Latapi, Caroline Gochanour, Hyunkeun Cho, et al.
Pageof 20